type 2 diabetes
Conditions
Interventions
swith from lispro or aspart to glirisine added 1 unit.
Sponsors
Fukuiken Saiseikai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) patient with type 1 or 2 diabetes treated with rpid acting insulin, lipro or aspart for moer than 12 weeks (2) HbA1c(NGSP) 7.5 - 10.5% (3) Duration of diabetes within 10 years (4) Age, 20 - 50 year old (5) Patients who can agree to take part in this study
Exclusion criteria
Exclusion criteria: -Patients who do not consent to the study. -Patients who have had severe ketosis or who have been in a diabetic coma or precoma within the past 6 months. -Patients who have a severe infection, are in pre/post operation, or have a serious wound. -Patients who are pregnant, lactating or may become pregnant. -Patients who have more than moderate kidney impairment (creatinine clearance is less than 30ml/min.) -Patients judged by their primary physician that they are not appropriate to participate the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. the diference of HbA1c 2. the diference of GA 3. GA/HbA1c (at 12th week, 24th week) 4. the rate of HbA1c 7.5% acheived | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. the diference of body weight 2. severe hypoglycemia needed a treatment in hospital 3. DTSQ 4. anyother adverse events and side effects | — |
Countries
Japan
Contacts
Public ContactKazuo Notsumata
Fukuiken Saiseikai Hospital Internal medicine
Outcome results
None listed